Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2005-06-30
2008-07-15
Shiao, Rei-Tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C562S405000, C514S506000, C514S557000, C514S237500, C514S255010, C560S026000
Reexamination Certificate
active
07399786
ABSTRACT:
Novel amino acid derivatives are provided that are useful for management of disorders such as obesity and immunological diseases. The derivatives are also useful in lowering blood glucose levels in hyperglycemic disorders and for treating related disorders such as body weight gain, elevated free fatty acid, cholesterol and triglyceride levels and other disorder exacerbated by obesity.
REFERENCES:
patent: 7087576 (2006-08-01), Nag et al.
Kato et al., 2002, CAS: 137:63252.
Horner et al., 1953, CAS 47:9185.
Gustak et al., 1956, CAS: 50:56697.
Jorgensen et al., 1963, CAS: 59: 35887.
Asquith et al., 1967, CAS: 67: 100407.
Lygo et al., 2004, CAS: 142: 219539.
Nishiyama et al., 1995, CAS: 122:106494.
Sonobe et al., Heterocycles, 1983, 20(3): 397-400.
Genevieve Pilon, et al., “Inhibition of Inductible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase”,J. Biol. Chem., 279, 20 (2004) pp. 20767-20774.
Sonia Kapur, et al., “Expression of Nitric Oxide Synthase in Skeletal Muscle”,Diabetes, 46 (1997) pp. 1691-1700.
Mylene Perreault, et al., “Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle”,Nature Medicine, 7, No. 10 (2001), pp. 1138-1143
Daniel S. Fletecher, et al. “Therapeutic Administration of a Selective Inhibitor of Nitric Oxide Synthase Does Not Ameliorate the Chronic Inflammation and Tissue Damage Associated with Adjuvant-Induced Arthritis in Rats”J. Pharm. Exp. Ther., 284, No. 2 (1998) pp. 714-721.
Gokhan S. Hotamisligil, et al., “Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link”,Diabetes, 43 (1994) pp. 1271-1278.
Ranjan Mukherjee, et al., “A Selective Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Modulator Blocks Adipocyte Differentiationn but Stimulates Glucose Uptake in 3T3-Li Adipocytes”,Mol. Endo., 14(9) (2000) pp. 1425-1433.
International Search Report, dated Feb. 16, 2007, from corresponding Internatinal Application No. PCT/US 06/25883, 2 pages.
Written Opinion of the International Searching Authority, dated Feb. 16, 2007, from corresponding International Application No. PCT/US06/25883.
Balse Preeti
Dey Debendranath
Nag Abjiheet
Nag Bishwajit
Neogi Partha
Bexel Pharmaceuticals Inc.
Shiao Rei-Tsang
Weaver Austin Villeneuve & Sampson LLP
LandOfFree
Derivatives of amino acids for treatment of obesity and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of amino acids for treatment of obesity and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of amino acids for treatment of obesity and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3965095